Head of Sales Italy at Acadia Pharmaceuticals

Milan, Lombardy, Italy

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Minimum 8 years of experience within pharmaceutical sector, with a proven record of leadership and commercial success
Experience leading managers or national sales teams within a matrix organization
Demonstrated experience across specialty prescription, pharmacy/OTC, and hospital channels
Proven track record in pharmaceutical marketing, product launches, and sales force effectiveness
Strong understanding of the Italian retail and pharmacy market, including established network with key wholesalers

Responsibilities

Develop, define and execute the national Sales Strategy aligned with Ferring’s business objectives and brand priorities
Develop and implement short- and long-term sales plans, including budget definition, performance monitoring, and control
Manage the Sales Budget (BUC) and ensure efficient allocation of resources across brands, channels, and regions
Lead, coach, and develop the Sales Team (3 Area Managers) to ensure performance excellence and strong field execution
Design and implement incentive plans to drive motivation and achievement of targets
Develop and maintain strong relationships with Key Opinion Leaders (KOLs) and prescribers in relevant therapeutic areas, main Italian Wholesalers (WHS) and leading pharmacy chains, key retail partners and pharmacy networks
Monitor national and regional sales performance, competitive dynamics, and market trends
Oversee implementation of SFE (Sales Force Effectiveness) processes including call plans, segmentation, and targeting
Support the introduction and launch of new products in collaboration with marketing and market access teams
Ensure compliance with pricing, distribution, and promotional policies
Identify business development opportunities leveraging Ferring’s portfolio and customer synergies
Collaborate closely with Market Access to ensure optimal access strategies across Italian regions, understanding local reimbursement and procurement dynamics
Represent Ferring at major congresses, scientific events, and industry meetings
Define, implement, and monitor the commercial strategy and sales plans for Ferring Italy, ensuring business growth, profitability, and market share expansion across all therapeutic areas and channels (prescription and retail)

Skills

Sales Leadership

Commercial Strategy

Team Management

Strategic Planning

Cross-Functional Collaboration

Market Expansion

Pharmaceutical Sales

Business Development

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free